2016
DOI: 10.1016/j.canlet.2015.11.038
|View full text |Cite
|
Sign up to set email alerts
|

Rapid on-site evaluation during endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis of hilar and mediastinal lymphadenopathy in patients with lung cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
30
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 47 publications
(32 citation statements)
references
References 25 publications
1
30
1
Order By: Relevance
“…In addition, we observed an increase in number of punctures per site of lymph node during the study, notably after starting using ROSE. This is in contrast to a recent report of less number of punctures needed when ROSE is used . We think both the introduction of ROSE and the increased experience among the endoscopy team may account for this results.…”
Section: Discussioncontrasting
confidence: 85%
“…In addition, we observed an increase in number of punctures per site of lymph node during the study, notably after starting using ROSE. This is in contrast to a recent report of less number of punctures needed when ROSE is used . We think both the introduction of ROSE and the increased experience among the endoscopy team may account for this results.…”
Section: Discussioncontrasting
confidence: 85%
“…To our knowledge, a positive impact of ROSE on accuracy in this setting was only observed in one retrospective univariate analysis of 236 patients with suspected lung cancer [17]. A lack of power could explain the overall difficulty in showing a significant impact of ROSE on accuracy and, indeed, the relatively good diagnostic yield of EBUS-TBNA contributes to this lack of power.…”
Section: Discussionmentioning
confidence: 99%
“…In 2 retrospective studies, ROSE did not improve the diagnostic yield of EBUS-TBNA [15, 16], but one of the studies reported an improvement of the adequacy of the sampled material [16]. In a recent retrospective trial, ROSE was shown to enhance the diagnostic yield [17]. A first randomized controlled trial failed to show an increased yield with ROSE in EBUS-TBNA, but was underpowered [18].…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, ROSE reduces turnaround time (ie, the amount of time taken to give a diagnosis) as no time is wasted looking for the more appropriate complementary test to take. Concordance between ROSE diagnosis and final diagnoses was found to be up to 98% …”
Section: Rapid On‐site Evaluation (Rose)mentioning
confidence: 99%